Prenatal screen revealed blood type A positive, antibody negative, group B strep status unknown, hepatitis B surface antigen negative, and rapid plasma reagin nonreactive.
She had a prior admission for preterm labor and received magnesium sulfate and betamethasone at that time.
Mother presented with preterm labor and premature rupture of membranes and poor biophysical profile of triplet I.
The baby was delivered by cesarean section.
He was extubated to continuous positive airway pressure on day of life one and weaned off of continuous positive airway pressure on day of life three to room air, where he has remained throughout the rest of his hospital stay.
The infant was started on caffeine prior to extubation, and he had intermittent episodes of apnea of bradycardia.
Caffeine was discontinued on day of life 33.
FLUIDS/ELECTROLYTES/NUTRITION ISSUES:  The infant had a peripherally inserted central catheter line placed for total parenteral nutrition.
Feeds were initiated on day of life two and were held during his course of indomethacin.
He was treated with vitamin E during his hospital course and is now no longer on vitamin E. Fer-In-[**Male First Name (un) **] was initiated once he reached full enteral feedings, and he is currently receiving 0.25 mL of Fer-In-[**Male First Name (un) **] once per day.
The infant had initial difficulty with hyponatremia with sodium levels as low as 126 on day of life eleven, for which he was treated with sodium chloride supplements.
His sodium responded nicely, and supplements were discontinued as he increased his kilocalories and began to take primarily formula.
GASTROINTESTINAL ISSUES:  The infant was placed on phototherapy on day of life two for a bilirubin of 6.5/0.2.
Phototherapy was discontinued on day of life nine.
The infant was treated with 48 hours of ampicillin and gentamicin.
The infant did not require any blood transfusions during the course of his hospitalization.
Feedings on discharge:  Enfamil 24 kilocalorie, by mouth ad lib.
Medications:  Ferrous sulfate 25 mg/mL 0.25 mL by mouth once per day.
Hepatitis B vaccine was received on [**2111-5-7**].
IMMUNIZATIONS RECOMMENDED:  Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  (1) born at less than 32 weeks gestation; (2) born between 32 and 35 weeks gestation with 2 of 3 of the following: plans for day care during respiratory syncytial virus season, with a smoker in the household, neuromuscular disease, airway abnormalities, or with school-age siblings; and/or (3) with chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
